A nurse provides teaching about the HPV vaccine. Which statement is ACCURATE?

HUMAN PAPILLOMAVIRUS (HPV) is the most common sexually transmitted infection in the US. Certain HPV strains cause: cervical cancer, vaginal and vulvar cancer, anal cancer, oropharyngeal cancer, penile cancer, and genital warts. HPV VACCINE (Gardasil 9): protects against 9 HPV strains (including types 16 and 18, which cause about 70% of cervical cancers, and types 6 and 11, which cause about 90% of genital warts). RECOMMENDED SCHEDULE: PRETEENS (11-12 years): best timing — before any sexual exposure; 2-DOSE series if started before age 15 (0 and 6-12 months apart); 3-DOSE series if starting at age 15 or older, or if immunocompromised; CATCH-UP: recommended through age 26 for those not vaccinated; shared clinical decision-making for adults 27-45 (less benefit at older ages due to prior exposure). MALES AND FEMALES: both benefit — prevents cancers in males too (anal, penile, oropharyngeal) and reduces transmission. PAP SMEARS: the HPV vaccine does NOT eliminate the need for cervical cancer screening (Pap smear/cervical cytology) — the vaccine doesn't protect against 100% of cancer-causing HPV strains; screening continues as recommended (starting at age 21 for most women, Pap every 3 years, or Pap + HPV co-test every 5 years starting at 30). SAFETY: the HPV vaccine is one of the most studied vaccines; common side effects are injection site reactions and brief fainting (syncope is relatively common with this vaccine — observe for 15 minutes post-injection). PN EDUCATION: address common misconceptions (it does NOT encourage sexual activity, it does NOT affect fertility); emphasize recommended age; document vaccine administration and counsel on side effects.